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Background
Repeated exposure to human immunodeficiency virus
(HIV) does not always result in acquiring infection.
Understanding the mechanisms that protect against pro-
gressive infection with HIV is important in understanding
correlates of protective immunity. We carried out this
study to determine the influence of host genetic factors
resistance to HIV infection and looked for established pol-
ymorphisms in chemokine (SDF-1, and RANTES) and
chemokine receptor genes (CCR5, CCR2, and CX3CR1).
Materials and methods
We studied 35 exposed but uninfected (EU) partners of
HIV-1 infected individuals for established polymor-
phisms in the above chemokine and chemokine receptor
genes by PCR-RFLP and compared the results with those
for 75 HIV-1 seronegative normal healthy controls (HC).
Results
There was no CCR5-32 deletion in any individual. Heter-
ozygous defects, in EU's, were seen in 32% for CCR2-64I,
34.3% for CX3CR1-280M, 20% for CX3CR1-249I, 31.4%
for SDF-3'A, 2.8% for RANTES-28G and 31.4% for
RANTES-403A. Homozygous inheritance of these muta-
tions was seen in less than 5% for all the above sites. There
was no significant difference between the prevalence of
these mutations between EU's and healthy individuals.
Conclusion
While several genetic aberrations in chemokine genes and
their receptors exist among EU's, there must be other
mechanisms that confer resistance to HIV infection in
these individuals.
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